These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29474346)

  • 1. Level of agreement between laboratory and point-of-care prothrombin time in patients after stopping or continuation of acenocoumarol anticoagulation: A comparison of diagnostic accuracy.
    de Vos EAJ; Hagen YJ; Meesters MI; Osmanovic N; Boer C; de Leeuw MA
    Eur J Anaesthesiol; 2018 Aug; 35(8):621-626. PubMed ID: 29474346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care testing and INR within-subject variation in patients receiving a constant dose of vitamin K antagonist.
    van den Besselaar AM; Biedermann JS; Kruip MJ
    Thromb Haemost; 2015 Nov; 114(6):1260-7. PubMed ID: 26202616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
    Fonseca MES; Balbi GGM; Signorelli F; Gouvea CP; de Andrade DCO
    Lupus; 2022 Apr; 31(5):565-574. PubMed ID: 35266798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery.
    Meesters MI; Vonk AB; van de Weerdt EK; Kamminga S; Boer C
    Thromb Res; 2014 Jun; 133(6):1141-4. PubMed ID: 24703296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
    Dillinger JG; Si Moussi T; Berge N; Bal Dit Sollier C; Henry P; Drouet L
    Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
    Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
    Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring.
    Ryan F; O'Shea S; Byrne S
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e26-33. PubMed ID: 19032373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study.
    Biedermann JS; van Rein N; van den Besselaar AM; Buhre PN; de Maat MP; van der Meer FJ; Leebeek FW; Kruip MJ
    J Thromb Haemost; 2016 Apr; 14(4):695-703. PubMed ID: 26806724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery.
    Okabayashi S; Ogawa S; Tanaka KA; Nishiyama T; Takeshita S; Nakayama Y; Nakajima Y; Sawa T; Mizobe T
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1609-1614. PubMed ID: 29395816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a point-of-care prothrombin time test after cardiopulmonary bypass in cardiac surgery.
    Meesters MI; Kuiper G; Vonk AB; Loer SA; Boer C
    Anaesthesia; 2016 Oct; 71(10):1163-8. PubMed ID: 27501250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
    Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H
    Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory Monitoring of Oral Vitamin K Anticoagulation.
    Moffat KA; Lewis CW
    Semin Thromb Hemost; 2017 Apr; 43(3):245-252. PubMed ID: 27677177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limits of agreement between measures obtained from standard laboratory and the point-of-care device Hemochron Signature Elite(R) during acute haemorrhage.
    Gauss T; Hamada S; Jurcisin I; Dahmani S; Boudaoud L; Mantz J; Paugam-Burtz C
    Br J Anaesth; 2014 Mar; 112(3):514-20. PubMed ID: 24335551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International normalized ratio monitoring of vitamin K antagonist therapy: comparative performance of point-of-care and laboratory-derived testing.
    Bonar R; Mohammed S; Favaloro EJ
    Semin Thromb Hemost; 2015 Apr; 41(3):279-86. PubMed ID: 25839866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of the avosure PT pro system compared with a hospital laboratory standard.
    Rigelsky JM; Choe HM; Curtis DM; Brosnan MJ; Mitrovich S; Streetman DS
    Ann Pharmacother; 2002 Mar; 36(3):380-5. PubMed ID: 11895047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transiently increased variation between a Point-of-Care and laboratory INR method after a long period of correlation: a case study demonstrating the need for ongoing correlation of POC with the central laboratory.
    Sephel GC; Laposata M
    Am J Clin Pathol; 2013 Oct; 140(4):475-86. PubMed ID: 24045543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin.
    Hoel RW; Albright RC; Beyer LK; Santrach PJ; Magtibay DL; Everson SL; McBane RD
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):99-104. PubMed ID: 18987294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.
    Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK
    Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Oral Anticoagulation Monitoring Study Group.
    Oral Anticoagulation Monitoring Study Group
    Am J Clin Pathol; 2001 Feb; 115(2):288-96. PubMed ID: 11211619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.